These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20850826)

  • 21. Editorial comment.
    Estrada C
    J Urol; 2009 Oct; 182(4 Suppl):1692-3; discussion 1693. PubMed ID: 19692038
    [No Abstract]   [Full Text] [Related]  

  • 22. Primary bladder neck dysfunction in children and adolescents II: results of treatment with alpha-adrenergic antagonists.
    Donohoe JM; Combs AJ; Glassberg KI
    J Urol; 2005 Jan; 173(1):212-6. PubMed ID: 15592078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of prazosin in men with symptoms of bladder neck obstruction and a non-hyperplastic prostate.
    Hedlund H; Andersson KE
    Scand J Urol Nephrol; 1989; 23(4):251-4. PubMed ID: 2480639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic possibilities of nicergoline in neurogenic bladder dysfunction].
    Gallego Gómez J; Jiménez Cruz JF; Martínez Agulló E; Mompó Sanchís JA; Llopis Mínguez B; Boronat Tormo F
    Arch Esp Urol; 1985; 38(2):175-90. PubMed ID: 2862846
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of alpha adrenergic blocker in the management of posterior urethral valves.
    Abraham MK; Nasir AR; Sudarsanan B; Puzhankara R; Kedari PM; Unnithan GR; Damisetti KR; Narayanan T
    Pediatr Surg Int; 2009 Dec; 25(12):1113-5. PubMed ID: 19727771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical comparison of selective and non-selective alpha 1A-adrenoceptor antagonists for bladder outlet obstruction associated with benign prostatic hyperplasia: studies on tamsulosin and terazosin in Chinese patients. The Chinese Tamsulosin Study Group.
    Na YJ; Guo YL; Gu FL
    J Med; 1998; 29(5-6):289-304. PubMed ID: 10503165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapy of benign prostatic hyperplasia with alpha receptor blockers].
    Stockamp K
    Urologe A; 1995 Jan; 34(1):3-8. PubMed ID: 7533449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Editorial comment.
    Combs AJ
    J Urol; 2010 Jun; 183(6):2372. PubMed ID: 20400154
    [No Abstract]   [Full Text] [Related]  

  • 29. Urodynamic and clinical effects of noninvasive and minimally invasive treatments in elderly men with lower urinary tract symptoms stratified according to the grade of obstruction.
    Witjes WP; Robertson A; Rosier PF; Neal DE; Debruyne FM; de la Rosette JJ
    Urology; 1997 Jul; 50(1):55-61. PubMed ID: 9218019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An observational urodynamic evaluation of men with lower urinary tract symptoms treated with doxazosin.
    Gerber GS; Kim JH; Contreras BA; Steinberg GD; Rukstalis DB
    Urology; 1996 Jun; 47(6):840-4. PubMed ID: 8677574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bladder neck dysfunction: the effect of the alpha-adrenergic blocking agent phentolamine on bladder neck dysfunction and a fluorescent histochemical study of bladder neck smooth muscle.
    Kaneko S; Minami K; Yachiku S; Kurita T
    Invest Urol; 1980 Nov; 18(3):212-8. PubMed ID: 6159335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Upper urinary tract urodynamics in vesico-ureteral reflux in children].
    Derzhavin VM; Vishnevskiĭ EL; Kazachkov SA; Li AV
    Urol Nefrol (Mosk); 1982; (2):11-5. PubMed ID: 7080302
    [No Abstract]   [Full Text] [Related]  

  • 33. Increased contractile response to phenylephrine in detrusor of patients with bladder outlet obstruction: effect of the alpha1A and alpha1D-adrenergic receptor antagonist tamsulosin.
    Bouchelouche K; Andersen L; Alvarez S; Nordling J; Bouchelouche P
    J Urol; 2005 Feb; 173(2):657-61. PubMed ID: 15643283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unstable bladder activity and the rate of resolution of vesico-ureteric reflux.
    Taylor CM
    Contrib Nephrol; 1984; 39():238-46. PubMed ID: 6744874
    [No Abstract]   [Full Text] [Related]  

  • 35. The measurement of lower urinary tract obstruction in infants and children.
    O'Donnell B; Vella L; Maloney M
    J Pediatr Surg; 1967 Dec; 2(6):518-22. PubMed ID: 6080295
    [No Abstract]   [Full Text] [Related]  

  • 36. Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia.
    Kaplan SA
    J Urol; 2005 Sep; 174(3):1011. PubMed ID: 16094031
    [No Abstract]   [Full Text] [Related]  

  • 37. [The unstable detrusor and vesico-ureteral reflux (a group of 20 children)].
    Kocvara R; Hanus T; Dvorácek J; Kríz J
    Cesk Pediatr; 1988 Nov; 43(11):667-70. PubMed ID: 3208342
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacologic treatment of lower urinary tract dysfunction in the female patient.
    Wein AJ
    Urol Clin North Am; 1985 May; 12(2):259-69. PubMed ID: 2859679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Drug therapy of benign prostatic hyperplasia].
    Vahlensieck W; Fabricius PG; Hell U
    Fortschr Med; 1996 Nov; 114(31):407-11. PubMed ID: 9036092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vesicoureteral reflux: the importance of etiology in management.
    King LR; Surian MA; Wendel RM; Burden JJ
    Trans Am Assoc Genitourin Surg; 1967; 59():110-5. PubMed ID: 6064514
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.